GlaxoSmithKline Pharmaceuticals Limited
GLAXO
Rank in Stocks
#3636
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Share Price
$27.54
Last synced: 2026-10-19
Market Cap
$4.67B
Change (1 day)
-2.73%
Change (1 year)
-11.86%
Country
IN
Trade GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Category
Healthcare
Stock split history for GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
GlaxoSmithKline Pharmaceuticals Limited stock (symbol: GLAXO) underwent a total of 1 stock splits.
The most recent stock split occurred on Sep 11, 2018.
One GLAXO share bought prior to Sep 11, 2018 would equal to 2 GLAXO shares today.
The most recent stock split occurred on Sep 11, 2018.
One GLAXO share bought prior to Sep 11, 2018 would equal to 2 GLAXO shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| 2018-09-11 | 2:1 | x2 | x2 |
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 4 | x15 |
US
|
|
| 7 | x432 |
US
|
|
| 0 | - |
US
|
|
| 7 | x226 |
US
|
|
| 2 | x10000 |
CH
|
